Neil Klompas

2020 - Zymeworks

In 2020, Neil Klompas earned a total compensation of $1.9M as President and Chief Operating Officer former CFO at Zymeworks, a 16% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$163,403
Option Awards$1,033,233
Salary$424,424
Stock Awards$264,000
Other$2,037
Total$1,887,097

Klompas received $1M in option awards, accounting for 55% of the total pay in 2020.

Klompas also received $163.4K in non-equity incentive plan, $424.4K in salary, $264K in stock awards and $2K in other compensation.

Rankings

In 2020, Neil Klompas' compensation ranked 5,776th out of 13,090 executives tracked by ExecPay. In other words, Klompas earned more than 55.9% of executives.

ClassificationRankingPercentile
All
5,776
out of 13,090
56th
Division
Manufacturing
2,377
out of 5,618
58th
Major group
Chemicals And Allied Products
951
out of 2,251
58th
Industry group
Drugs
823
out of 1,951
58th
Industry
Pharmaceutical Preparations
613
out of 1,456
58th
Source: SEC filing on November 25, 2022.

Klompas' colleagues

We found three more compensation records of executives who worked with Neil Klompas at Zymeworks in 2020.

2020

Ali Tehrani

Zymeworks

Chief Executive Officer

2020

Diana Hausman

Zymeworks

Chief Medical Officer

2020

Anthony Polverino

Zymeworks

Chief Scientific Officer

News

In-depth

You may also like